| Market revenue in 2025 | USD 282.6 million |
| Market revenue in 2033 | USD 562.6 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Consumables |
| Fastest growing segment | Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Consumables, Instruments |
| Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
Increasing R&D initiatives and clinical trials in the country are anticipated to create a growth environment for the market. High focus of regional pharma companies to develop novel vaccines and therapeutics is anticipated to drive the demand for cell separation solutions.
For instance, in September 2020, Spain initiated clinical trials of Johnson & Johnson COVID-19 vaccine. In addition, Spain shows immense growth potential in cell separation solutions due to an increasing interest of investors in innovative biological therapies.
For instance, in June 2020, Spain-based Ona Therapeutics closed a USD 33.1 million Series A funding for development of novel anti-metastasis cancer drugs. Furthermore, increasing government support for R&D activities is anticipated to positively affect the market growth.
Publish Date: Aug 04, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Terumo Corp | View profile | 30,207 | 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 | www.terumo.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | www.bd.com |
| Corning Inc | View profile | 49,800 | One Riverfront Plaza, Corning, NY, United States, 14831 | www.corning.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | www.stemcell.com |
| Akadeum Life Sciences | View profile | 11-50 | Ann Arbor, Michigan, United States, North America | akadeum.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Cell Separation Market Outlook will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.93% in 2025.
Horizon Databook has segmented the Spain cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing R&D initiatives and clinical trials in the country are anticipated to create a growth environment for the market. High focus of regional pharma companies to develop novel vaccines and therapeutics is anticipated to drive the demand for cell separation solutions.
For instance, in September 2020, Spain initiated clinical trials of Johnson & Johnson COVID-19 vaccine. In addition, Spain shows immense growth potential in cell separation solutions due to an increasing interest of investors in innovative biological therapies.
For instance, in June 2020, Spain-based Ona Therapeutics closed a USD 33.1 million Series A funding for development of novel anti-metastasis cancer drugs. Furthermore, increasing government support for R&D activities is anticipated to positively affect the market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain Cell Separation Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Spain Cell Separation Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
